LBF20207PG44: Difference between revisions

Latest revision as of 17:35, 21 October 2010

Upper classes: LB LBF

Prostaglandin F₂α alcohol

Structural Information
	(1,9α,11α,15S) -Tetrahydroxyprosta- (cis-5,trans-13) -dien
	Prostaglandin F₂α alcohol (1,9α,11α,15S) -Tetrahydroxyprosta- (5Z,13E) -dien

Formula	C20H36O4
Exact Mass	340.26135963999997
Average Mass	340.49744
SMILES	`C(CC[C@H](O)C=C[C@H]([C@H]1CC=CCCCCO)[C@@H](C[C@@H]1O)O)CC`
Physicochemical Information









	PGF2 alpha Alcohol is reported to retain ocular hypotensive properties , but the target receptor is not cleared yet. Woodward_DF et al.


Spectral Information
Mass Spectra
UV Spectra
IR Spectra
NMR Spectra
Other Spectra
Chromatograms

Reported Metabolites, References

Biospecies	ID	Compound Name	Reference	Comment
n.a.	LBF20207PG44	See above.	Woodward_DF et al. 2000

@@ Line 1: / Line 1: @@
+{{Lipid/Header}}
 {{Hierarchy|{{PAGENAME}}}}
@@ Line 4: / Line 6: @@
 |LipidBank=XPR1783
 |LipidMaps=LMFA03010113
-|SysName=1,9a,11a,15S-tetrahydroxyprosta-5Z,13E-dien
+|SysName=(1,9alpha,11alpha,15S) -Tetrahydroxyprosta-  (cis-5,trans-13) -dien
-|Common Name=&&Prostaglandin F2a Alcohol&&
+|Common Name=&&Prostaglandin F_2 alpha alcohol&&(1,9alpha,11alpha,15S) -Tetrahydroxyprosta- (5Z,13E) -dien&&
+|Source=
+|Chemical Synthesis=
+|Metabolism=
+|Biological Activity=PGF2 alpha  Alcohol is reported to retain ocular hypotensive properties <!--2157-->, but the target receptor is not cleared yet.[[Reference:Woodward_DF:Krauss_AH:Chen_J:Gil_DW:Kedzie_KM:Protzman_CE:Shi_L:Chen_R:Krauss_HA:Bogardus_A_et_al:,Br. J. Pharmacol.,2000,130,1933|{{RelationTable/GetFirstAuthor|Reference:Woodward_DF:Krauss_AH:Chen_J:Gil_DW:Kedzie_KM:Protzman_CE:Shi_L:Chen_R:Krauss_HA:Bogardus_A_et_al:,Br. J. Pharmacol.,2000,130,1933}}]]
 }}
+{{Lipid/Footer}}